Ligand validation:6AT2

ATP: ADENOSINE-5'-TRIPHOSPHATE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AT2_ATP_A_701	97%	44%	0.07	0.988	0.96	1.19	1	1	0	0	100%	1
2OLR_ATP_A_541	98%	39%	0.06	0.981	1.08	1.31	3	4	0	0	100%	1
6CRT_ATP_A_601	97%	41%	0.069	0.987	1.06	1.21	2	3	0	0	100%	1
6ASM_ATP_A_701	96%	42%	0.077	0.989	0.99	1.26	2	3	0	0	100%	0.9687
6ASI_ATP_A_601	95%	44%	0.08	0.986	0.93	1.24	1	3	0	0	100%	1
2OLQ_ATP_A_541	95%	38%	0.071	0.975	1.24	1.19	4	1	0	0	100%	0.981
2PNN_ATP_A_374	100%	30%	0.027	0.995	1.34	1.43	4	5	2	0	100%	0.9774
5J1T_ATP_A_401	100%	31%	0.03	0.994	1.31	1.43	2	7	0	0	100%	1
1XDN_ATP_A_501	100%	45%	0.03	0.99	1	1.14	2	3	0	0	100%	1
3MHY_ATP_C_113	100%	53%	0.034	0.992	0.86	0.94	-	2	0	0	100%	1
4CBU_ATP_A_1369	100%	50%	0.045	0.997	0.68	1.25	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.